Archive

Post Archive: Alex Spira MD PhD FACP

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

October 8, 2018
Read More

Co Author Alex Spira, MD - Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

September 25, 2018
Read More

Alex Spira, M.D., PhD, F.A.C.P. receives award for his work in Lung Cancer

September 20, 2018
Read More

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

May 22, 2018
Read More

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

April 26, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

March 6, 2018
Read More

Alex Spira, MD Co-Author of collaborative study on Immunotherapy guidelines to guide clinicians and patients

February 15, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

February 7, 2018
Read More

Northern Virginia 2018 Thoracic Oncology Symposium, CME Program - March 10th 2018

January 30, 2018
Read More